ALL ORAL COMBINATION OF VINORELBINE AND CAPECITABILE AS A FIRST LINE TREATMENT IN PATIENTS (PTS) WITH METASTATIC BREAST CANCER (MBC)

被引：0
|
作者：
Shehata, Samir [1 ]
Khalaf, Marwa [1 ]
机构：
[1] Assiut Univ, Dept Med Oncol, Assiut, Egypt
来源：
BREAST | 2017年 / 36卷
关键词：
D O I：
10.1016/S0960-9776(17)30706-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO87
引用
收藏
页码：S53 / S53
页数：1
相关论文
共 50 条
  • [31] Prediction of benefit from treatment beyond the first line in patients with metastatic breast cancer (MBC).
    Bonotto, Marta
    Gerratana, Lorenzo
    Minisini, Alessandro
    Poletto, Elena
    Russo, Stefania
    Andreetta, Claudia
    Mansutti, Mauro
    Fasola, Gianpiero
    Puglisi, Fabio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [32] Efficacy and safety of weekly oral vinorelbine (NVBO) as single agent in first- or second-line metastatic breast cancer (MBC)
    Morales, Serafin
    Blancas, Isabel
    Luisa Gonzalvez, Maria
    Barnadas, Agust
    Diaz, Nieves
    Servitja, Sonia
    del Barco, Sonia
    Margeli, Mireia
    Garcia Carbonero, Iciar
    Alvarez, Ruth
    Helena Lopez de Ceballos, Maria
    Javier Perez, Francisco
    Llombart Cussac, Antonio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [33] Oral Vinorelbine (VNR) and Capecitabine (CAP) - an Acceptable and Effective Combination Chemotherapy for Early Metastatic Breast Cancer (MBC)
    Hogg, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : S112 - S112
  • [34] ORAL VINORELBINE (VNR) AND CAPECITABINE (CAP): AN ACCEPTABLE AND EFFECTIVE COMBINATION CHEMOTHERAPY FOR EARLY METASTATIC BREAST CANCER (MBC)
    Hogg, Martin
    Birkenhead, Lauren
    Hennigan, Claire
    Roebuck, Nikki
    [J]. BREAST, 2013, 22 : S41 - S41
  • [35] Vinorelbine (V) plus docetaxel (D) followed by Capecitabine (C) as first-line treatment of metastatic breast cancer (MBC)
    不详
    [J]. EJC SUPPLEMENTS, 2006, 4 (02): : 168 - 169
  • [36] A clinical phase II study of cisplatin and vinorelbine followed by docetaxel as first-line treatment in metastatic breast cancer (MBC).
    Yassine, H
    Khalifeh, M
    Bitar, N
    Charafeddine, M
    Dheiny, M
    Chehal, A
    Jalloul, R
    Dandashi, A
    Wehbeh, M
    Shamseddine, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 83S - 83S
  • [37] Oral paclitaxel in the treatment of metastatic breast cancer (MBC) patients.
    Dai, Ming-Shen
    Chao, Ta-Chong
    Chiu, Chang-Fan
    Lu, Yen-Shen
    Shiah, Her-Shyongi
    Wu, Yi-Yin
    Cheng, Wei-Hong
    Chan, Wing Kai
    Hung, Tak
    Hung, Noelyn
    Cutler, David
    Kwan, Rudolf
    Kramer, Douglas
    Chao, Tsu-Yi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [38] Capecitabine (X) in the first-line treatment of metastatic breast cancer (MBC).
    Harbeck, N.
    Kaufmann, M.
    Siedentopf, F.
    Dalivoust, P.
    Debled, M.
    Robert, N. J.
    O'Shaughnessy, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [39] Vinorelbine and capecitabine combination as first-line treatment in patients with metastatic breast cancer: Final results of a multicentric trial in Egypt
    Elghazaly, H.
    Tawfik, H.
    Mahrous, M.
    Meshref, M. M.
    Sakr, A.
    Haddad, N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [40] VINORELBINE AND DOCETAXEL COMBINATION AS FIRST LINE TREATMENT IN PATIENTS WITH METASTATIC BREAST CANCER - RESULTS OF A MULTICENTRIC PHASE II TRIAL IN IRAN
    Ameri, A.
    Shahrad, B.
    Madani, H.
    Fazlalizadeh, A.
    Mousavizadeh, A.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 119 - 119
12345